Pluri Inc
NASDAQ:PLUR

Watchlist Manager
Pluri Inc Logo
Pluri Inc
NASDAQ:PLUR
Watchlist
Price: 5.45 USD -9.77% Market Closed
Market Cap: 29.8m USD
Have any thoughts about
Pluri Inc?
Write Note

Pluri Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pluri Inc
Cost of Revenue Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pluri Inc
NASDAQ:PLUR
Cost of Revenue
-$4k
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
10%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cost of Revenue
-$1.1m
CAGR 3-Years
28%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cost of Revenue
-$89.7m
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Cost of Revenue
-$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cost of Revenue
-$8.7m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pluri Inc's Cost of Revenue?
Cost of Revenue
-4k USD

Based on the financial report for Jun 30, 2024, Pluri Inc's Cost of Revenue amounts to -4k USD.

What is Pluri Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
10%

Over the last year, the Cost of Revenue growth was 56%.

Back to Top